The Dutch Flutemetamol in Young Dementia Study.
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2017
Price : $35 *
At a glance
- Drugs Flutemetamol-F-18 (Primary)
- Indications Dementia
- Focus Biomarker; Diagnostic use; Registrational
- 02 Feb 2017 Status changed from recruiting to completed.
- 16 Jul 2014 Results published in a GE Healthcare media release.
- 13 Dec 2012 New trial record